Substance Use Tools & Resources    

This Clinical Practice Guideline (CPG) provides an evidence-based framework for evaluating, treating, and managing the individual needs of patients with substance use disorders (SUD), including alcohol use disorder, in the VA and DoD. It is intended for use by all VA and DoD healthcare providers.

This Opioid Prevention Campaign toolkit translates the science of prevention into simple strategies parents and caregivers can incorporate into busy daily lives -- to do what we can to protect our kids from developing an addiction later in life.

This revised version of the CRAFFT screening tool incorporates changes that enhance the sensitivity of this well-validated and widely-utilized adolescent substance use screening tool to accurately identify adolescents at risk for a substance use disorder. It also presents new recommended clinician talking points, informed by the latest science and clinician feedback.

This guideline develops a framework to evaluate existing clinical practice guidelines for prescribing opioids for acute pain indications and recommends indications for which new evidence-based guidelines should be developed.

This tool outlines a framework for implementing adolescent SBIRT within primary care. The framework includes operational guidance for adopting strategies to create optimal conditions for change, as well as clinical areas for action for SBIRT implementation. 

This statement provides an overview of the effect of the opioid crisis on the mother-infant dyad and provide recommendations for management of the infant with opioid exposure, including clinical presentation, assessment, treatment, and discharge.

A fact sheet which outlines new strategies that can reduce the risks from polysubstance use.

The Opioid Prevention Campaign is a public health media campaign to help prevent adolescent substance use. The stress and uncertainty that surrounds COVID-19 has resulted in a rise in drug and alcohol use. Take action today to prevent opioid use disorder among teens and adolescents.

This report considers issues related to acute and chronic pain management and substance use disorders (SUD). It answers two guiding questions: (1) What are the priority gaps in QM science that need to be filled in order to reduce opioid use disorders (OUD

The PAMI Pain Management and Dosing Guide is a free tool for use by health care providers in hospital, EMS, or acute care settings. Content was developed after extensive literature review of pain, sedation, and analgesia medications for acute pain, chronic pain and procedural sedation in all ages. The guide was developed and reviewed by a multidisciplinary team of physicians, nurses, pain specialists, and pharmacists. Dosing ranges should be used as a general guide and adapted to specific patient characteristics such as age and comorbidities. The guide includes oral, nasal, parenteral and topical medications for acute and chronic pain, anxiety, and procedural sedation as well as patient safety, discharge planning and nonpharmacologic management information.